Quantification of Myocardial Flow Reserve Using Positron Emission Imaging. The Journey to Clinical Use

Journal of the American College of Cardiology

Volumn 54, Issue 2, 2009, Pages 157-159

  Beanlands, Rob S B ^a   Ziadi, Maria Cecilia ^a   Williams, Kathryn ^a  

^a National Cardiac PET Centre   (Canada)

Author keywords

13N ammonia; coronary flow reserve; myocardial perfusion imaging; outcome; positron emission tomography

Indexed keywords

AMMONIA N 13; VASODILATOR AGENT;

ANGINA PECTORIS; CLINICAL EVALUATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; FLOW MEASUREMENT; HEART HEMODYNAMICS; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AMMONIA; CORONARY CIRCULATION; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENCE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOISOTOPES; SURVIVAL RATE; SWITZERLAND;

EID: 67649522787     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.03.049     Document Type: Editorial

References (33)

1. The Quotations Page. http://www.quotationspage.com/quote/24004.html Accessed May 3, 2009
2. 13N-ammonia myocardial perfusion positron emission tomography: added value of coronary flow reserve. J Am Coll Cardiol 54 (2009) 150-156
3. Gould K.L., Lipscomb K., and Hamilton G.W. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 33 (1974) 87-94
4. Hachamovitch R., Rozanski A., Hayes S.W., et al. Predicting therapeutic benefit from myocardial revascularization procedures: Are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary?. J Nucl Cardiol 13 (2006) 768-778
5. Lertsburapa K., Ahlberg A., Bateman T., et al. Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease. J Nuc Cardiol 15 (2008) 745-753
6. Yoshinaga K., Chow B.J., Williams K., et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography?. J Am Coll Cardiol 48 (2006) 1029-1039
7. Beanlands R.S., Chow B.J., Dick A., et al. CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease-executive summary. Can J Cardiol 23 (2007) 107-119
8. deKemp R.A., Yoshinaga K., and Beanlands R.S.K. Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow?. J Nucl Cardiol 14 (2007) 380-397
9. Camici P.G., and Crea F. Coronary microvascular dysfunction. N Engl J Med 356 (2007) 830-840
10. Parkash R., deKemp R.A., Ruddy T.D., et al. Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol 11 (2004) 440-449
11. Schelbert H.R., Phelps M.E., Huang S.C., et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 63 (1981) 1259-1272
12. Uren N.G., Melin J.A., De Bruyne B., et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 330 (1994) 1782-1788
13. Muzik O., Beanlands R.S., Hutchins G.D., et al. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 34 (1993) 83-91
14. Kaufmann P.A., Gnecchi-Ruscone T., Yap J.T., Rimoldi O., and Camici P.G. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. J Nucl Med 40 (1999) 1848-1856
15. Nagamachi S., Czernin J., Kim A.S., et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med 37 (1996) 1626-1631
16. Neglia D., Michelassi C., Trivieri M.G., et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 105 (2002) 186-193
17. Cecchi F., Olivotto I., Gistri R., et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349 (2003) 1027-1035
18. Tio R.A., Dabeshlim A., Slart R., et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 50 (2009) 214-219
19. Tsukamoto T., Morita K., Naya1 M., et al. Myocardial flow reserve is influenced by both coronary artery stenosis severity and coronary risk factors in patients with suspected coronary artery disease. Eur J Nucl Med Mol Imaging 33 (2006) 1150-1156
20. Altman D.G., and Bland J.M. Statistics notes: Interaction revisited: the difference between two estimates. BMJ 326 (2003) 219
21. Wang R., Lagakos S.W., Ware J.H., Hunter D.J., and Drazen J.M. Statistics in medicine-reporting of subgroup analyses in clinical trials. N Engl J Med 357 (2007) 2189-2194
22. Geltman E.M., Henes C.G., Senneff M.J., Sobel B.E., and Bergmann S.R. Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries. J Am Coll Cardiol 16 (1990) 596-598
23. Kaufmann P.A., Gnecchi-Ruscone T., Schafers K.P., Luscher T.F., and Camici P.G. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 36 (2000) 103-109
24. 82Rb PET imaging and coronary artery stenosis severity. Eur J Nucl Med Mol Imaging 35 (2008) 1593-1601
25. Lortie M., Beanlands R.S., deKemp R.A., et al. Quantification of myocardial blood flow with 82-Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging 34 (2007) 1765-1774
26. Yalamanchili P., Wexler E., Hayes M., et al. Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent. J Nucl Cardiol 14 (2007) 782-788
27. Madar I., Ravert H.T., Du Y., et al. Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. J Nucl Med 47 (2006) 1359-1366
28. 99mTc-tetrofosmin. J Nucl Med 48 (2007) 1021-1030
29. Plössla K., Chandraa R., Qua W., et al. A novel gallium bisaminothiolate complex as a myocardial perfusion imaging agent. Nucl Med Biol 35 (2008) 83-90
30. Utz W., Greiser A., Niendorf T., Dietz R., and Schulz-Menger J. Single- or dual-bolus approach for the assessment of myocardial perfusion reserve in quantitative MR perfusion imaging. Magn Reson Med 59 (2008) 1373-1377
31. Lee T.Y. Functional CT: physiological models. Trans Biotech 20 (2002) S3-S10
32. Petretta M., Soricelli A., Storto G., and Cuocolo A. Assessment of coronary flow reserve using single photon emission computed tomography with technetium 99m-labeled tracers. J Nucl Cardiol 15 (2008) 456-465
33. DeMaria A. Comparative effectiveness research. J Am Coll Cardiol 53 (2009) 973-975